Funds holding “Boston Scientific Corp”
Which closed-end funds own a security? Searches the latest N-PORT snapshot of every active fund. Enter a ticker (issuer-level: matches the vendor-mapped ticker), a CUSIP or ISIN (security-level: one specific bond or share class), or part of a name.
18 positions across 18 funds. Weights are percent of net assets from each fund’s latest N-PORT; report dates differ by fund.
| Fund | Position | Identifier | Type | Weight | Value (USD) | Report date | Coverage |
|---|---|---|---|---|---|---|---|
| THQ abrdn Healthcare Opportunities Fund Healthcare | Boston Scientific Corp | 101137107 | EC | 1.89% | $19.8M | Jun 30, 2026 | full (109 positions) |
| THW abrdn World Healthcare Fund Healthcare | Boston Scientific Corp | 101137107 | EC | 1.67% | $11.5M | Jun 30, 2026 | full (131 positions) |
| BME BlackRock Health Sciences Trust Healthcare | Boston Scientific Corp | 101137107 | EC | 1.30% | $7.4M | Jun 30, 2026 | full (152 positions) |
| HQH abrdn Healthcare Investors Healthcare | Boston Scientific Corp | 101137107 | EC | 1.02% | $13.8M | Jun 30, 2026 | full (154 positions) |
| BMEZ BlackRock Health Sciences Term Trust Healthcare | Boston Scientific Corp | 101137107 | EC | 0.94% | $10.2M | Jun 30, 2026 | full (170 positions) |
| CII BlackRock Enhanced Large Cap Core Fund U.S. Equity | Boston Scientific Corp | 101137107 | EC | 0.90% | $9.7M | Jun 30, 2026 | full (81 positions) |
| LGI Lazard Global Total Return & Income Fund Multi-Asset | Boston Scientific Corp | 101137107 | EC | 0.60% | $1.6M | Jun 30, 2026 | full (107 positions) |
| JCE Nuveen Core Equity Alpha Fund U.S. Equity | Boston Scientific Corp | 101137107 | EC | 0.55% | $1.7M | Jun 30, 2026 | full (144 positions) |
| GRX Gabelli Healthcare & WellnessRx Trust Healthcare | BOSTON SCIENTIFIC CORP | 101137107 | EC | 0.39% | $881K | Jun 30, 2026 | full (195 positions) |
| NMAI Nuveen Multi-Asset Income Fund Multi-Asset | Boston Scientific Corp | 101137107 | EC | 0.26% | $1.8M | Jun 30, 2026 | full (1,176 positions) |
| USA Liberty All Star Equity Fund U.S. Equity | Boston Scientific Corp | 101137107 | EC | 0.24% | $4.8M | Jun 30, 2026 | full (148 positions) |
| ECAT BlackRock ESG Capital Allocation Term Trust U.S. Equity | Boston Scientific Corp | 101137107 | EC | 0.15% | $2.5M | Jun 30, 2026 | full (1,193 positions) |
| CSQ Calamos Strategic Total Return Fund Multi-Asset | Boston Scientific Corp | 101137107 | EC | 0.11% | $5.6M | Jul 31, 2026 | full (820 positions) |
| GAB Gabelli Equity Trust U.S. Equity | BOSTON SCIENTIFIC CORP | 101137107 | EC | 0.11% | $2.5M | Jun 30, 2026 | full (709 positions) |
| BCAT BlackRock Capital Allocation Term Trust U.S. Equity | Boston Scientific Corp | 101137107 | EC | 0.09% | $1.5M | Jun 30, 2026 | full (1,148 positions) |
| ETW Eaton Vance Tax-Managed Global Buy-Write Opportunities Fund Covered Call / Option Income | Boston Scientific Corp | 101137107 | EC | 0.07% | $854K | Jun 30, 2026 | full (258 positions) |
| GOF Guggenheim Strategic Opportunities Fund Multi-Asset | BOSTON SCIENTIFIC CORP | 101137107 | EC | 0.00% | $12.6K | May 29, 2026 | full (1,841 positions) |
| CPZ Calamos Long/Short Equity & Dynamic Income Trust U.S. Equity | Boston Scientific Corp | 101137107 | EC | -0.14% | $-361K | Jul 31, 2026 | full (761 positions) |
Matching position names
Historical holdings reports are not a real-time portfolio. Security-level matching (CUSIP/ISIN) distinguishes a company’s bonds, common shares, preferreds and derivatives; issuer-level matching groups them by name or ticker and is labelled as such. See the overlap tool to compare two portfolios.